Journal Articles - Journal Articles
|
A pilot program of HIV pre-exposure prophylaxis in Thai youth
Rungmaitree S, Werarak P, Pumpradit W, Phongsamart W, Lapphra K, Wittawatmongkol O, Durier Y, Maleesatharn A, Kuttiparambil B, Cressey TR, Hoffman RM, Chokephaibulkit K. PLoS One. 2024 Feb 22;19(2):e0298914. doi: 10.1371/journal.pone.0298914. PMID: 38386680; PMCID: PMC10883585. |
|
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries
Kakaraskoska Boceska B, Vilken T, Xavier BB, Kostyanev T, Lin Q, Lammens C, Ellis S, O'Brien S, da Costa RMA, Cook A, Russell N, Bielicki J, Riddell A, Stohr W, Walker AS, Berezin EN, Roilides E, De Luca M, Romani L, Ballot D, Dramowski A, Wadula J, Lochindarat S, Boonkasidecha S, Namiiro F, Ngoc HTB, Tran MD, Cressey TR, Preedisripipat K, Berkley JA, Musyimi R, Zarras C, Nana T, Whitelaw A, da Silva CB, Jaglal P, Ssengooba W, Saha SK, Islam MS, Mussi-Pinhata MM, Carvalheiro CG, Piddock LJV, Heath PT, Malhotra-Kumar S, Sharland M, Glupczynski Y, Goossens H. Nat Commun. 2024 May 10;15(1):3947. doi: 10.1038/s41467-024-48296-z. PMID: 38729951 PMCID: PMC11087563 |
|
Can a Fraction of the Dolutegravir Dispersible Tablet Solution be Used to Dose Neonates?
Phogole CM, Bekker A, Cressey TR, Ferris W, Decloedt E, and Kellermann T. J Acquir Immune Defic Syndr. 2024 Aug 1;96:376–379. |
|
D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years
Turkova A, Chan MK, Kityo C, Kekitiinwa AR, Musoke P, Violari A, Variava E, Archary M, Cressey TR, Chalermpantmetagul S, Sawasdichai K, Ounchanum P, Kanjanavanit S, Srirojana S, Srirompotong U, Welch S, Bamford A, Epalza C, Fortuny C, Colbers A, Nastouli E, Walker S, Carr D, Conway M, Spyer MJ, Parkar N, White I, Nardone A, Thomason MJ, Ferrand RA, Giaquinto C, Ford D; D3 trial team. Contemp Clin Trials. 2024 Jul;142:107540. doi: 10.1016/j.cct.2024.107540. Epub 2024 Apr 16. PMID: 38636725. |
|
Development and field evaluation in African and Asian countries of an hepatitis B virus PCR on open polyvalent platforms to determine treatment eligibility: results from the "Agence Nationale de Recherche sur le Sida et les hépatites" 12327 study
Kania D, Nouhin J, Bolloré K, Njouom R, Toni TD, Maiga AI, Toure-Kane C, Ngo-Giang-Huong N, Dagnra A, Chuong Le DH, Lunel-Fabiani F, Castera-Guy J, Rubbo PA, Pisoni A, Plantier JC, Tuaillon E. Clin Microbiol Infect. 2024 May 11:S1198-743X(24)00236-2. doi: 10.1016/j.cmi.2024.05.002. Epub ahead of print. PMID: 38735369. |
|
Expanding options of child-friendly, single-tablet regimens for young children with HIV
Lancet HIV. 2024 May;11(5):e275-e276. doi: 10.1016/S2352-3018(24)00007-9. Epub 2024 Apr 12. PMID: 38621390 |
|
Molnupiravir versus favipiravir in at-risk outpatients with COVID-19: A randomized controlled trial in Thailand
Salvadori N, Jourdain G, Krittayaphong R, Siripongboonsitti T, Kongsaengdao S, Atipornwanich K, Sakulkonkij P, Angkasekwinai N, Sirijatuphat R, Chusri S, Mekavuthikul T, Apisarnthanarak A, Srichatrapimuk S, Sungkanuparph S, Kirdlarp S, Phongnarudech T, Sangsawang S, Napinkul P, Achalapong J, Khusuwan S, Pratipanawat P, Nookeu P, Danpipat N, Leethong P, Hanvoravongchai P, Sukrakanchana PO, Auewarakul P. Int J Infect Dis. 2024 Jun;143:107021. doi: 10.1016/j.ijid.2024.107021. Epub 2024 Mar 30. PMID: 38561040. |
|
Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial
Bekker A, Salvadori N, Rabie H, du Toit S, Than-In-At K, Groenewald M, Cressey R, Nielsen J, Capparelli EV, Lallemant M, Cotton MF, Cressey TR, PETITE-ABC/3TC-LPVr Study Team. Lancet HIV. 2024 Feb;11(2):e86-e95. doi: 10.1016/S2352-3018(23)00289-8. PMID: 38296364. |
|
Pharmacokinetics of Generic Pediatric Dolutegravir Dispersible Tablet in Thai Young Children Living With HIV Weighing Below Twenty Kilograms
Rungsapphaiboon A, Wacharachaisurapol N, Anugulruengkitt S, Sirikutt P, Phasomsap C, Tawan M, Saisaengjan C, Na Nakorn Y, Paiboon N, Songtaweesin WN, Tawon Y, Cressey TR, Puthanakit T; DTGkids Study Team. Pediatr Infect Dis J. 2024 May 20. doi: 10.1097/INF.0000000000004366. Online ahead of print.
|
|
Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa
PMID: 38247190 |
|
Population pharmacokinetics of ravidasvir in adults with chronic hepatitis C virus infection and impact of antiretroviral treatment
Antimicrob Agents Chemother. 2024 May 20:e0000824. doi: 10.1128/aac.00008-24. Online ahead of print. PMID: 38767383 |
|
Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries
Aghokeng AF, Ngo-Giang-Huong N, Huynh THK, Dagnra AY, D'Aquin Toni T, Maiga AI, Dramane K, Eymard-Duvernay S, Chaix ML, Calvez V, Descamps D; ANRS12425 Study Group. J Antimicrob Chemother. 2024 May 2;79(5):1164-1168. doi: 10.1093/jac/dkae087. PMID: 38546752. |
|
Prevention of HBV infection
Chen HL, Jourdain G. Clin Liver Dis (Hoboken). 2024 Jun 12;23(1):e0194. doi: 10.1097/CLD.0000000000000194. PMID: 38872782; PMCID: PMC11168846. |
|
Real-world evidence of survival benefit of remdesivir: study of 419 propensity score-matched patients hospitalized over the alpha and delta waves of COVID-19 in New Orleans, LA.
Salvadori N, Fridman M, Chiang M, Chen L, Wang C, Lee E, Fonseca V, Fusco DN, Jourdain G, Drouin AC. Front Med (Lausanne). 2024 May 16;11:1390164. doi: 10.3389/fmed.2024.1390164. PMID: 38818394; PMCID: PMC11137210. |
|
Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age
Bekker A, Yang J, Wang J, Cotton MF, Cababasay M, Wiesner L, Moye J, Browning R, Nakwa FL, Rabie H, Violari A, Mirochnick M, Cressey TR, Capparelli EV. Pediatr Infect Dis J. 2024 Apr 1;43(4):355-360. doi: 10.1097/INF.0000000000004243. Epub 2024 Jan 4. PMID: 38190642 PMCID: PMC10939833 |
|
Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trial
Abdalla S, Compagnucci A, Riault Y, Chan MK, Bamford A, Nolan A, Ramos JT, Constant V, Nguyen T-N, Zheng Y, Tréluyer J-M, Froelicher-Bournaud L, Neveux N, Saidi Y, Cressey TR, Hirt D; SMILE study group. Antimicrob Agents Chemother. 2024 Feb 7;68(2):e0100423. doi: 10.1128/aac.01004-23. Epub 2023 Dec 11. PMID: 38092664; PMCID: PMC10848770. |
|
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate-Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum
Hoffman RM, Brummel S, Ziemba L, Chinula L, McCarthy K, Fairlie L, Jean-Philippe P, Chakhtoura N, Johnston B, Krotje C, Nematadzira TG, Nakayiwa F, Ndyanabangi V, Hanley S, Theron G, Violari A, João E, Correa MD Jr, Hofer CB, Navanukroh O, Aurpibul L, Nevrekar N, Zash R, Shapiro R, Stringer JSA, Currier JS, Sax P, Lockman S; IMPAACT 2010/VESTED Study Team. Clin Infect Dis. 2024 Jun 14;78(6):1617-1628. doi: 10.1093/cid/ciae001. PMID: 38180851; PMCID: PMC11175665 (available on ) |
|
A Single-Tube Colorimetric Loop-Mediated Isothermal Amplification for Rapid Detection of SARS-CoV-2 RNA
Hongjaisee S, Kham-Kjing N, Musikul P, Daengkaokhew W, Kongson N, Guntala R, Jaiyapan N, Kline E, Panpradist N, Ngo-Giang-Huong N, Khamduang W. Diagnostics (Basel). 2023 Sep 25;13(19):3040. doi: 10.3390/diagnostics13193040. PMID: 37835783; PMCID: PMC10572433. |
|
Abacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight Bands
Chupradit S, Wamalwa DC, Maleche-Obimbo E, Kekitiinwa AR, Mwanga-Amumpaire J, Bukusi EA, Nyandiko WM, Mbuthia JK, Swanson A; DNDi Clinical Team; Cressey TR, Punyawudho B, Musiime V. J Pediatric Infect Dis Soc. 2023 Nov 30;12(11):574-580. doi: 10.1093/jpids/piad082. PMID: 37798141; PMCID: PMC10756690. |
|
Are International Units of Anti-HBs Antibodies Always Indicative of Hepatitis B Virus Neutralizing Activity?
Aronthippaitoon Y, Szerman N, Ngo-Giang-Huong N, Laperche S, Ungeheuer M-N, Sureau C, Khamduang W, Gaudy-Graffin C. Vaccines. 2023; 11(4):791. doi: 10.3390/vaccines11040791. |
|
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial.
Chinula L, Ziemba L, Brummel S, McCarthy K, Coletti A, Krotje C, Johnston B, Knowles K, Moyo S, Stranix-Chibanda L, Hoffman R, Sax PE, Stringer J, Chakhtoura N, Jean-Philippe P, Korutaro V, Cassim H, Fairlie L, Masheto G, Boyce C, Frenkel LM, Amico KR, Purdue L, Shapiro R, Mmbaga BT, Patel F, van Wyk J, Rooney JF, Currier JS, Lockman S; IMPAACT 2010/VESTED Study Team and Investigators. Lancet HIV. 2023 Jun;10(6):e363-e374. doi: 10.1016/S2352-3018(23)00061-9. Epub 2023 May 8. PMID: 37167996; PMCID: PMC10280394. |
|
Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014
Rungmaitree S, Aurpibul L, Best BM, Li X, Warshaw MG, Wan H, Tobin NH, Jumes P, Leavitt R, McCarthy K, Scheckter R, Ounchanum P, Violari A, Teppler H, Campbell H, Krotje C, Townley E, Moye J, Melvin AJ; IMPAACT 2014 study team. J Pediatric Infect Dis Soc. 2023 Dec 16;12(12):602-609. doi: 10.1093/jpids/piad078. PMID: 37815035. |
|
Hepatitis B prevalence and associated factors in adults presenting
Salvadori N, Gauthier L, Guy M, Ngo-Giang-Huong N, Khamduang W, Decker L, Achalapong J, Mary JY, Sirirungsi W, Pornprasert S, Arunothong S, Ongwandee S, Jourdain G. J Virus Erad. 2023 Dec 7;9(4):100356. doi: 10.1016/j.jve.2023.100356. PMID: 38161321; PMCID: PMC10755356. |
|
Novel approaches to postnatal prophylaxis to eliminate vertical transmission of HIV
Ruel T, Penazzato M, Zech JM, Archary M, Cressey TR, Goga A, Harwell J, Landovitz RJ, Lain MG, Lallemant M, Namusoke-Magongo E, Mukui I, Permar SR, Prendergast AJ, Shapiro R, Abrams EJ. Glob Health Sci Pract. 2023 Apr 28;11(2):e2200401. doi: 10.9745/GHSP-D-22-00401. PMID: 37116934; PMCID: PMC10141432. |
|
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
Compagnucci A, Chan MK, Saïdi Y, Cressey TR, Bamford A, Riault Y, Coelho A, Nolan A, Chalermpantmetagul S, Morkunaite G, Amuge P, Musiime V, Violari A, Cotton M, Kekitiinwa AR, Kaudha E, Groenewald M, Liberty AA, Kanjanavanit S, Volokha A, Bologna R, Pavia Ruz N, Prieto Tato L, Paioni P, Marques L, Reliquet V, Niehues T, Welch SB, Ford D, Giaquinto C, Gibb DM, Babiker A, Ramos Amador JT; SMILE-PENTA17-ANRS 152 Trial Group. EClinicalMedicine. 2023 Jun 2;60:102025. doi: 10.1016/j.eclinm.2023.102025. PMID: 37304494; PMCID: PMC10251070. |
|
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)
Russell NJ, Stöhr W, Plakkal N, Cook A, Berkley JA, Adhisivam B, Agarwal R, Ahmed NU, Balasegaram M, Ballot D, Bekker A, Berezin EN, Bilardi D, Boonkasidecha S, Carvalheiro CG, Chami N, Chaurasia S, Chiurchiu S, Colas VRF, Cousens S, Cressey TR, de Assis ACD, Dien TM, Ding Y, Dung NT, Dong H, Dramowski A, Ds M, Dudeja A, Feng J, Glupczynski Y, Goel S, Goossens H, Hao DTH, Khan MI, Huertas TM, Islam MS, Jarovsky D, Khavessian N, Khorana M, Kontou A, Kostyanev T, Laoyookhon P, Lochindarat S, Larsson M, Luca M, Malhotra-Kumar S, Mondal N, Mundhra N, Musoke P, Mussi-Pinhata MM, Nanavati R, Nakwa F, Nangia S, Nankunda J, Nardone A, Nyaoke B, Obiero CW, Owor M, Ping W, Preedisripipat K, Qazi S, Qi L, Ramdin T, Riddell A, Romani L, Roysuwan P, Saggers R, Roilides E, Saha SK, Sarafidis K, Tusubira V, Thomas R, Velaphi S, Vilken T, Wang X, Wang Y, Yang Y, Zunjie L, Ellis S, Bielicki JA, Walker AS, Heath PT, Sharland M. PLoS Med. 2023 Jun 8;20(6):e1004179. doi: 10.1371/journal.pmed.1004179. PMID: 37289666; PMCID: PMC10249878. |
|
Pharmacogenomics of clozapine in schizophrenia patients and associations with efficacy and adverse drug reactions
Nopphadol Nuntamool1*, Salinee Jantrapirom2,3, Rewadee Jenraumjit4, Arphawan Phlaichum5, Porntip Apiwatnakorn5, Tim R. Cressey6, Yardpiroon Tawon6, Pimonpan Jinda7,8, Aroonrut Lucksiri Nuntamool N, Jantrapirom S, Jenraumjit R, Phlaichum A, Apiwatnakorn P, Cressey TR, Tawon Y, Jinda P, Lucksiri A. IJPS, 2023; 19(3): 27-41.
|
|
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s
Van Schalkwyk M, Bekker A, Decloedt E, Wang J, Theron GB, Cotton MF, Eke AC, Cressey TR, Shapiro DE, Bacon K, Knowles K, George K, Browning R, Chakhtoura N, Rungruengthanakit K, Wiesner L, Capparelli EV, Stek AM, Mirochnick M, Best BM; IMPAACT P1026s Protocol Team. Antimicrob Agents Chemother. 2023 Nov 15;67(11):e0073723. doi: 10.1128/aac.00737-23. Epub 2023 Oct 26. PMID: 37882552; PMCID: PMC10648924. |
|
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014
Melvin AJ, Yee KL, Gray KP, Yedla M, Wan H, Tobin NH, Teppler H, Campbell H, McCarthy K, Scheckter R, Aurpibul L, Ounchanum P, Rungmaitree S, Cassim H, McFarland E, Flynn P, Cooper E, Krotje C, Townley E, Moye J, Best BM; IMPAACT 2014 study team. J Acquir Immune Defic Syndr. 2023 Feb 1;92(2):153-161. doi: 10.1097/QAI.0000000000003116. PMID: 36215957; PMCID: PMC9839475 (available on ) |
|
Population pharmacokinetics of unbound and total dolutegravir concentrations in children aged 12?years and older: a PK substudy of the SMILE trial
Abdalla S, Compagnucci A, Zheng Y, Tréluyer JM, Saidi Y, Ramos JT, Coelho A, Riault Y, Cressey TR, Hirt D; SMILE study group. J Antimicrob Chemother. 2023 Apr 3;78(4):1041-1049. doi: 10.1093/jac/dkad043. PMID: 36869720. |
|
A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial
Kawichai S, Songtaweesin WN, Wongharn P, Phanuphak N, Cressey TR, Moonwong J, Vasinonta A, Saisaengjan C, Chinbunchorn T, Puthanakit T. JMIR Mhealth Uhealth. 2022 Apr 21;10(4):e25561. doi: 10.2196/25561. PMID: 35451976; PMCID: PMC9073624. |
|
Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study
Bekker A, Capparelli EV, Violari A, Cotton MF, Cababasay M, Wang J, Mathiba R, Wiesner L, Wiznia A, Samson P, Browning R, Moye J, Nakwa FL, Decloedt E, Rabie H, Mirochnick M, Cressey TR; IMPAACT P1106 team. Lancet HIV. 2022 Jan;9(1):e24-e31. doi: 10.1016/S2352-3018(21)00266-6. Epub 2021 Dec 6. PMID: 34883066; PMCID: PMC8760861. |
|
Activity of Propolis Nanoparticles against HSV-2: Promising Approach to Inhibiting Infection and Replication
Sangboonruang S, Semakul N, Sookkree S, Kantapan J, Ngo-Giang-Huong N, Khamduang W, Kongyai N, Tragoolpua K. Molecules. 2022 Apr 15;27(8). doi: 10.3390/molecules27082560. PMID: 35458758; PMCID: PMC9032435. |
|
Advancing the prevention and treatment of HIV in children: priorities for research and development
Penazzato M, Townsend CL, Sam-Agudu NA, Ruel TD, Archary M, Bekker A, Cressey TR, Colbers A, Sugandhi N, Rojo P, Rakhmanina N, Watkins M, Frigati L, Mukui I, Hafiz A, Vicari M, Capparelli EV, Abrams EJ; PADO-HIV 5 participants. Lancet HIV. 2022 Sep;9(9):e658-e666. doi: 10.1016/S2352-3018(22)00101-1. Epub 2022 Jul 18. PMID: 35863362. |
|
Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial
Turner RM, Turkova A, Moore CL, Bamford A, Archary M, Barlow-Mosha LN, Cotton MF, Cressey TR, Kaudha E, Lugemwa A, Lyall H, Mujuru HA, Mulenga V, Musiime V, Rojo P, Tudor-Williams G, Welch SB, Gibb DM, Ford D, White IR; the ODYSSEY Trial Team. BMC Med Res Methodol. 2022 Feb 20;22(1):49. doi: 10.1186/s12874-022-01539-3. PMID: 35184739; PMCID: PMC8858505. |
|
Chronic Kidney Disease in a Large National Human Immunodeficiency Virus Treatment Program
Paengsai N, Noppakun K, Jourdain G, Cressey TR, Salvadori N, Chaiwarith R, Tantraworasin A, Mary JY, Bowonwatanuwong C, Bhakeecheep S, Traisathit P, Kosachunhanun N. Healthcare (Basel). 2022 Aug 8;10(8):1490. doi: 10.3390/healthcare10081490. PMID: 36011147; PMCID: PMC9408286. |
|
Clinical and population-based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy
Brummel SS, Stringer J, Mills E, Tierney C, Caniglia EC, Colbers A, Chi BH, Best BM, Gaaloul ME, Hillier S, Jourdain G, Khoo SH, Mofenson LM, Myer L, Nachman S, Stranix-Chibanda L, Clayden P, Sachikonye M, Lockman S. J Int AIDS Soc. 2022 Jul;25 Suppl 2:e25917. doi: 10.1002/jia2.25917. PMID: 35851758. PMCID: PMC9294861 |
|
Comparison of Simple RNA Extraction Methods for Molecular Diagnosis of Hepatitis C Virus in Plasma
Hongjaisee S, Jabjainai Y, Sakset S, Preechasuth K, Ngo-Giang-Huong N, Khamduang W. Diagnostics (Basel). 2022 Jun 30;12(7):1599. doi: 10.3390/diagnostics12071599. PMID: 35885505; PMCID: PMC9322174. |
|
Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study
Tapsoba JD, Cover J, Obong'o C, Brady M, Cressey TR, Mori K, Okomo G, Kariithi E, Obanda R, Oluoch-Madiang D, Chen YQ, Drain P, Duerr A. PLoS Med. 2022 Sep 12;19(9):e1004097. doi: 10.1371/journal.pmed.1004097. PMID: 36095005; PMCID: PMC9521917. |
|
Editorial: dying while waiting for a hepatitis B cure?
Jourdain G, Panpradist N. Aliment Pharmacol Ther. 2022 Aug;56(3):550-551. doi: 10.1111/apt.17081. PMID: 35804475. |
|
Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV-1 in Lao People's Democratic Republic
Paboriboune P, Phongsavan K, Arounlangsy P, Flaissier B, Aphayarath O, Phimmasone P, Banchongphanith K, Xayaovong M, Jourdain G, Schott AM, Saadatian-Elahi M, Magaud L, Klich A, Ngo-Giang-Huong N, Heard I, Rabilloud M, Picot VS, Longuet C. Cancer Med. 2022 May;11(9):1984-1994. doi: 10.1002/cam4.4502. Epub 2022 Mar 8. PMID: 35257506; PMCID: PMC9089224. |
|
Gaps in Accessibility of Pediatric Formulations: A Cross-Sectional Observational Study of a Teaching Hospital in Northern Thailand
Tiengkate P, Lallemant M, Charoenkwan P, Angkurawaranon C, Kanjanarat P, Suwannaprom P, Borriharn P. Children (Basel). 2022 Feb 22;9(3):301. doi: 10.3390/children9030301. PMID: 35327673; PMCID: PMC8947278. |
|
Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Jesson J, Crichton S, Quartagno M, Yotebieng M, Abrams EJ, Chokephaibulkit K, Le Coeur S, Aké-Assi MH, Patel K, Pinto J, Paul M, Vreeman R, Davies MA, Ben-Farhat J, Van Dyke R, Judd A, Mofenson L, Vicari M, Seage G 3rd, Bekker LG, Essajee S, Gibb D, Penazzato M, Collins IJ, Wools-Kaloustian K, Slogrove A, Powis K, Williams P, Matshaba M, Thahane L, Nyasulu P, Lukhele B, Mwita L, Kekitiinwa-Rukyalekere A, Wanless S, Goetghebuer T, Thorne C, Warszawski J, Galli L, van Rossum AMC, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaya L, Navarro M, Frick A, Naver L, Kahlert C, Volokha A, Chappell E, Pape JW, Rouzier V, Marcelin A, Succi R, Sohn AH, Kariminia A, Edmonds A, Lelo P, Lyamuya R, Ogalo EA, Odhiambo FA, Haas AD, Bolton C, Muhairwe J, Tweya H, Sylla M, D'Almeida M, Renner L, Abzug MJ, Oleske J, Purswani M, Teasdale C, Nuwagaba-Biribonwoha H, Goodall R, Leroy V. J Int AIDS Soc. 2022 Mar;25(3):e25871. doi: 10.1002/jia2.25871. PMID: 35255197; PMCID: PMC8901148. |
|
Highly Specific and Rapid Detection of Hepatitis C Virus Using RT-LAMP-Coupled CRISPR-Cas12 Assay
Kham-Kjing N, Ngo-Giang-Huong N, Tragoolpua K, Khamduang W, Hongjaisee S. Diagnostics (Basel). 2022 Jun 23;12(7):1524. doi: 10.3390/diagnostics12071524. PMID: 35885430; PMCID: PMC9317538. |
|
Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
Johnson KA, Niu X, Glidden DV, Castillo-Mancilla JR, Yager J, MaWhinney S, Morrow M, Okochi H, Cressey TR, Drain PK, Gandhi M, Anderson PL, Spinelli MA. Open Forum Infect Dis. 2021 Apr 17;8(7):ofab200. doi: 10.1093/ofid/ofab200. PMID: 34285929; PMCID: PMC8286091. |
|
One dose does not fit all: revising the WHO paediatric dosing tool to include the non-linear effect of body size and maturation
Denti P, Wasmann RE, Francis J, McIlleron H, Sugandhi N, Cressey TR, Mirochnick M, Capparelli EV, Penazzato M; WHO Pediatric Antiretroviral Working Group. Lancet Child Adolesc Health. 2022 Jan;6(1):9-10. doi: 10.1016/S2352-4642(21)00302-3. Epub 2021 Oct 20. PMID: 34678142. |
|
Outcomes of etravirine-based antiretroviral treatment in treatment-experienced children and adolescents living with HIV in Europe and Thailand
European Pregnancy And Paediatric Infections Cohort Collaboration Eppicc, Lyons A, Thompson L, Chappell E, Ene L, Galli L, Goetghebuer T, Jourdain G, Noguera-Julian A, Kahlert CR, Königs C, Kosalaraksa P, Lumbiganon P, Marczy?ska M, Marques L, Navarro M, Naver L, Okhonskaia L, Prata F, Puthanakit T, Ramos JT, Samarina A, Thorne C, Voronin E, Turkova A, Giaquinto C, Judd A, Collins IJ. Antivir Ther. 2022 Jun;27(3):13596535221092182. doi: 10.1177/13596535221092182. PMID: 36029009. |
|
Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children
Morin S, Lallemant M, Garcia-Prats A, Lewis L, Watkins M, Giaquinto C, Valentin M, Penazzato M, Reeder JC; Global Accelerator for Paediatric Formulations (GAP-f). Pediatr Infect Dis J. 2022 Jan 1;41(1):e1-e5. doi: 10.1097/INF.0000000000003331. PMID: 34784302; PMCID: PMC8658058. |
|
Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study
Bekker A, Rabie H, Salvadori N, du Toit S, Than-In-At K, Groenewald M, Andrieux-Meyer I, Kumar M, Cressey R, Nielsen J, Capparelli E, Lallemant M, Cotton MF, Cressey TR; PETITE Study Team. J Acquir Immune Defic Syndr. 2022 Mar 1;89(3):324-331. doi: 10.1097/QAI.0000000000002871. PMID: 34855626; PMCID: PMC8826609. |
|
Point-of-care semi-quantitative test for adherence to tenofovir alafenamide or tenofovir disoproxil fumarate
Sevenler D, Niu X, Dossantos S, Toner M, Cressey TR, Sandlin RD, Drain PK. J Antimicrob Chemother. 2022 Mar 31;77(4):996-999. doi: 10.1093/jac/dkab487. PMID: 35038336; PMCID: PMC9126064. |
|
Prevalences of SARS-CoV-2 RNA and anti-SARS-CoV-2 among at-risk populations in Chiang Mai and Lamphun provinces, Thailand, during November 2020-January 2021
Takalay S, Ngo-Giang-Huong N, Kongnim W, Mongkolwat P, Phoseng P, Wangsaeng N, Hongjaisee S, Butr-Indr B, Tragoolpua K, Jourdain G, Pornprasert S, Khamduang W. PLoS One. 2022 Feb 2;17(2):e0263127. doi: 10.1371/journal.pone.0263127. PMID: 35108302; PMCID: PMC8809620 |
|
Proximal tubular dysfunction in pregnant women receiving tenofovir disoproxil fumarate to prevent mother-to-child transmission of hepatitis B virus
Liegeon G, Ngo-Giang-Huong N, Salvadori N, Bunpo P, Cressey R, Achalapong J, Kanjanavikai P, Patamasingh Na Ayudhaya O, Prommas S, Siriwachirachai T, Sabsanong P, Yves Mary J, Jourdain G. J Antimicrob Chemother. 2022 Mar 31;77(4):1111-1118. doi: 10.1093/jac/dkab490. PMID: 35045168; PMCID: PMC9126070. |
|
Systems Challenges in Accessing Medicines among Children under Thailand's Universal Health Coverage: A Qualitative Study of a Provincial Public Hospital Network
Daojorn R, Suwannaprom P, Suttajit S, Kanjanarat P, Tiengket P, Lallemant M. Children (Basel). 2022 Apr 13;9(4):552. doi: 10.3390/children9040552. PMID: 35455597; PMCID: PMC9029722. |
|
Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring
Niu X, Kubiak RW, Siriprakaisil O, Klinbuyaem V, Sukrakanchana PO, Cressey R, Okochi H, Gandhi M, Cressey TR, Drain PK. Open Forum Infect Dis. 2022 Aug 10;9(8):ofac405. doi: 10.1093/ofid/ofac405. PMID: 36004315; PMCID: PMC9394764. |
|
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies
Jacobs TG, Schouwenburg S, Penazzato M, Archary M, Ruel TD, van den Anker J, Burger DM, Cressey TR, Abrams EJ, Lyall H, Bekker A, Colbers A; Penta Clinical Pharmacology Working Group; PADO-HIV 5 participants. Lancet HIV. 2022 Sep;9(9):e649-e657. doi: 10.1016/S2352-3018(22)00121-7. Epub 2022 Jul 18. PMID: 35863363. |
|
Zika Virus Immunoglobulin G Seroprevalence among Young Adults Living with HIV or without HIV in Thailand from 1997 to 2017
Choyrum S, Wangsaeng N, Nechba A, Salvadori N, Saisom R, Achalapong J, Putiyanun C, Sabsanong P, Sangsawang S, Patamasingh Na Ayudhaya O, Jourdain G, Ngo-Giang-Huong N, Khamduang W. Viruses. 2022 Feb 10;14(2). doi: 10.3390/v14020368. PMID: 35215960; PMCID: PMC8878279 |
|
Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children
Turkova A, White E, Mujuru HA, Kekitiinwa AR, Kityo CM, Violari A, Lugemwa A, Cressey TR, Musoke P, Variava E, Cotton MF, Archary M, Puthanakit T, Behuhuma O, Kobbe R, Welch SB, Bwakura-Dangarembizi M, Amuge P, Kaudha E, Barlow-Mosha L, Makumbi S, Ramsagar N, Ngampiyaskul C, Musoro G, Atwine L, Liberty A, Musiime V, Bbuye D, Ahimbisibwe GM, Chalermpantmetagul S, Ali S, Sarfati T, Wynne B, Shakeshaft C, Colbers A, Klein N, Bernays S, Saïdi Y, Coelho A, Grossele T, Compagnucci A, Giaquinto C, Rojo P, Ford D, Gibb DM; ODYSSEY Trial Team. N Engl J Med. 2021 Dec 30;385(27):2531-2543. doi: 10.1056/NEJMoa2108793. PMID: 34965338. |
|
Effective and Safe Daclatasvir Drug Exposures Predicted in Children Using Adult Formulations
Cressey TR, Abbassi M, Lallemant M, Indolfi G, Al-Nahari M, Farid S, Penazzato M, Easterbrook P, El-Sayed MH. Pediatr Infect Dis J. 2021 Dec 1;40(12):1081-1086. doi: 10.1097/INF.0000000000003282. PMID: 34321444. |
|
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
Andrieux-Meyer I, Tan SS, Thanprasertsuk S, Salvadori N, Menétrey C, Simon F, Cressey TR, Said HRHM, Hassan MRA, Omar H, Tee HP, Chan WK, Kumar S, Thongsawat S, Thetket K, Avihingsanon A, Khemnark S, Yerly S, Ngo-Giang-Huong N, Siva S, Swanson A, Goyal V, Bompart F, Pécoul B, Murad S. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):448-458. doi: 10.1016/S2468-1253(21)00031-5. Epub 2021 Apr 16. PMID: 33865507. |
|
Impact of Zika virus on the human type I interferon osteoimmune response
Drouin A, Wallbillich N, Theberge M, Liu S, Katz J, Bellovoda K, Se Yun Cheon S, Gootkind F, Bierman E, Zavras J, Berberich MJ, Kalocsay M, Guastaldi F, Salvadori N, Troulis M, Fusco DN. Cytokine. 2021 Jan;137:155342. doi: 10.1016/j.cyto.2020.155342. Epub 2020 Oct 30. PMID: 33130337. |
|
Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015
Ngo-Giang-Huong N, Leroi C, Fusco D, Cressey TR, Wangsaeng N, Salvadori N, Kongyai N, Sirirungsi W, Lallemant M, Auewarakul P, Khamduang W, Jourdain G. Viruses. 2021 Jul 22;13(8). doi: 10.3390/v13081423. PMID: 34452289; PMCID: PMC8402824 |
|
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies
Moore CL, Turkova A, Mujuru H, Kekitiinwa A, Lugemwa A, Kityo CM, Barlow-Mosha LN, Cressey TR, Violari A, Variava E, Cotton MF, Archary M, Compagnucci A, Puthanakit T, Behuhuma O, Sa?di Y, Hakim J, Amuge P, Atwine L, Musiime V, Burger DM, Shakeshaft C, Giaquinto C, Rojo P, Gibb DM, Ford D; ODYSSEY Trial Team. BMC Infect Dis. 2021 Jan 4;21(1):5. doi: 10.1186/s12879-020-05672-6. PMID: 33446115; PMCID: PMC7809782. |
|
Outbreaks of COVID-19 in Nursing Homes: A Cross-Sectional Survey of 74 Nursing Homes in a French Area
Piet E, Maillard A, Mallaval FO, Dusseau JY, Galas-Haddad M, Ducki S, Creton H, Lallemant M, Forestier E, Gavazzi G, Delory T. J Clin Med. 2021 Sep 21;10(18):4280. doi: 10.3390/jcm10184280. PMID: 34575392; PMCID: PMC8468632. |
|
Prevalence of High-Risk Human Papillomavirus Infections before and after Cervical Lesion Treatment, among Women Living with HIV
Dub T, Le Cœur S, Ngo-Giang-Huong N, Matanasarawut W, Suriyachai P, Saisawat K, Putiyanun C, Buranabanjasatean S, Leenasirimakul P, Randaeng S, Delory T. J Clin Med. 2021 Jul 15;10(14). doi: 10.3390/jcm10143133. PMID: 34300302; PMCID: PMC8305309 |
|
Reply to 'Evidence against in utero transmission of hepatitis B virus'
Terrault NA, Cheung KW, Levy MT, Jourdain G. Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):445-446. doi: 10.1038/s41575-021-00456-y. PMID: 33888888. |
|
Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes
Bardon AR, Dorward J, Sookrajh Y, Sayed F, Quame-Amaglo J, Pillay C, Feutz E, Ngobese H, Simoni JM, Sharma M, Cressey TR, Gandhi M, Lessells R, Moodley P, Naicker N, Naidoo K, Thomas K, Celum C, Abdool Karim S, Garrett N, Drain PK. BMJ Open. 2021 Oct 5;11(10):e050116. doi: 10.1136/bmjopen-2021-050116. PMID: 34610939; PMCID: PMC8493905. |
|
Uncommon hepatitis C virus among migrant sex workers in Chiangmai, Thailand
Hongjaisee S, Khamduang W, Sripan P, Choyrum S, Thepbundit V, Kosashunhanan N, Ngo-Giang-Huong N, Tangmunkongvorakul A. Clin Microbiol Infect. 2021 Oct;27(10):1523-1525. doi: 10.1016/j.cmi.2021.05.013. Epub 2021 May 17. PMID: 34015529 |
